Perioperative HMG-CoA-Reductase-Inhibitors: A Pilot Study Assessing the Role of "Statin" Therapy and Perioperative Inflammatory Response in Patients Undergoing Major Orthopedic Surgery

Trial Profile

Perioperative HMG-CoA-Reductase-Inhibitors: A Pilot Study Assessing the Role of "Statin" Therapy and Perioperative Inflammatory Response in Patients Undergoing Major Orthopedic Surgery

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 23 May 2017

At a glance

  • Drugs Simvastatin (Primary) ; Simvastatin (Primary)
  • Indications Atherosclerosis
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 03 Jun 2014 Planned End Date changed from 1 Jun 2013 to 1 Apr 2015 as reported by ClinicalTrials.gov record.
    • 22 May 2012 Planned End Date changed from 1 Jun 2011 to 1 Jun 2013 as reported by ClinicalTrials.gov record.
    • 19 Apr 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top